Hiroshi Yotsuyanagi

1.1k total citations
12 papers, 907 citations indexed

About

Hiroshi Yotsuyanagi is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Hiroshi Yotsuyanagi has authored 12 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Hiroshi Yotsuyanagi's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Hiroshi Yotsuyanagi is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Hiroshi Yotsuyanagi collaborates with scholars based in Japan, United States and Uganda. Hiroshi Yotsuyanagi's co-authors include Shiro Iino, Kazuhiko Koike, Kiyoshi Kurokawa, Takeshi Okanoue, Masashi Mizokami, Etsuro Orito, Hiroshi Sakugawa, Kojiro Michitaka, Kazuyoshi Ishikawa and Takafumi Ichida and has published in prestigious journals such as Hepatology, Cancer and Journal of Virology.

In The Last Decade

Hiroshi Yotsuyanagi

8 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Yotsuyanagi Japan 6 727 660 138 70 48 12 907
Runu Chakravarty India 24 1.0k 1.4× 902 1.4× 253 1.8× 119 1.7× 40 0.8× 63 1.4k
Guaniri Mateu United States 8 328 0.5× 382 0.6× 183 1.3× 115 1.6× 9 0.2× 9 668
Rachel Trowbridge Australia 16 308 0.4× 340 0.5× 182 1.3× 121 1.7× 48 1.0× 26 691
Thomas Tu Australia 21 1.3k 1.8× 1.1k 1.7× 271 2.0× 148 2.1× 138 2.9× 61 1.6k
Bisheng Shi China 14 601 0.8× 373 0.6× 224 1.6× 162 2.3× 44 0.9× 31 931
Valerie S. Greco-Stewart Canada 11 154 0.2× 127 0.2× 134 1.0× 101 1.4× 10 0.2× 17 390
Andrea Sbardellati Italy 8 149 0.2× 179 0.3× 91 0.7× 39 0.6× 14 0.3× 10 356
Severin O. Gudima United States 17 630 0.9× 574 0.9× 145 1.1× 168 2.4× 13 0.3× 42 769
Catherine Jamard France 18 585 0.8× 456 0.7× 126 0.9× 250 3.6× 32 0.7× 29 772

Countries citing papers authored by Hiroshi Yotsuyanagi

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Yotsuyanagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Yotsuyanagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Yotsuyanagi more than expected).

Fields of papers citing papers by Hiroshi Yotsuyanagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Yotsuyanagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Yotsuyanagi. The network helps show where Hiroshi Yotsuyanagi may publish in the future.

Co-authorship network of co-authors of Hiroshi Yotsuyanagi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Yotsuyanagi. A scholar is included among the top collaborators of Hiroshi Yotsuyanagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Yotsuyanagi. Hiroshi Yotsuyanagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Furusawa, Yuri, Maki Kiso, Ryuta Uraki, et al.. (2025). Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures. Journal of Virology. 99(3). e0221724–e0221724.
2.
Ikeuchi, Kazuhiko, Makoto Saito, Kazuya Okushin, et al.. (2025). Comparative effectiveness of antiviral treatment on household transmission of SARS-CoV-2: a retrospective cohort study using administrative data. BMC Infectious Diseases. 25(1). 1213–1213.
3.
Takahashi, Kazuaki, Takeya Tsutsumi, Keiko Arai, et al.. (2025). Characterization of genetic mutations in hepatitis B virus isolated from HBsAg+/HBcAb+/HBsAb-/HBV DNA + Japanese blood donors. Scientific Reports. 15(1). 31265–31265.
4.
Okushin, Kazuya, Tatsuya Kanto, Masaaki Korenaga, et al.. (2024). Real‐world trends in acute viral hepatitis in Japan: A nationwide questionnaire‐based survey. Hepatology Research. 55(3). 301–308.
5.
Tsutsumi, Takeya & Hiroshi Yotsuyanagi. (2024). Comorbidities and Contraindicated Medications in Patients with Chronic Hepatitis C Infection in Japan: a Real-World Database Study. Kanzo. 65(8). 368–390. 2 indexed citations
6.
Yoshino, Yusuke, et al.. (2010). Pseudomonas putida bacteremia in adult patients: five case reports and a review of the literature. Journal of Infection and Chemotherapy. 17(2). 278–282. 87 indexed citations
7.
Orito, Etsuro, Masashi Mizokami, Hiroshi Sakugawa, et al.. (2001). A Case–Control Study for Clinical and Molecular Biological Differences Between Hepatitis B Viruses of Genotypes B and C. Hepatology. 33(1). 218–223. 350 indexed citations
8.
Shintani, Yoshizumi, Hiroshi Yotsuyanagi, Hajime Fujie, et al.. (2000). The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C. Cancer. 88(11). 2478–2486. 48 indexed citations
9.
Yotsuyanagi, Hiroshi, Yoshizumi Shintani, Hajime Fujie, et al.. (1998). Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology. 27(5). 1377–1382. 144 indexed citations
10.
Yotsuyanagi, Hiroshi. (1997). Hepatitis G virus in the liver and serum of patients with hepatocellular carcinoma. Hepatology Research. 8(1). 21–27. 4 indexed citations
11.
Koike, Kazuhiko, Kyoji Moriya, Shiro Iino, et al.. (1994). High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 19(4). 810–819. 230 indexed citations
12.
Yotsuyanagi, Hiroshi, Shiro Iino, Kazuhiko Koike, et al.. (1993). Duration of viremia in human hepatitis a viral infection as determined by polymerase chain reaction. Journal of Medical Virology. 40(1). 35–38. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Runu Chakravarty Breakdown of academic impact, for papers by Guaniri Mateu Breakdown of academic impact, for papers by Rachel Trowbridge Breakdown of academic impact, for papers by Thomas Tu Breakdown of academic impact, for papers by Bisheng Shi Breakdown of academic impact, for papers by Valerie S. Greco-Stewart Breakdown of academic impact, for papers by Andrea Sbardellati Breakdown of academic impact, for papers by Severin O. Gudima Breakdown of academic impact, for papers by Catherine Jamard
Rankless by CCL
2026